We systematically analyzed the prevalence and function of ALAb in both hospitalized-unvaccinated and non-hospitalized breakthrough COVID-19 patients and found IgM ALAb in both groups, especially in moderate/severe patients, which was still detectable during convalescence. The gene discussed is CD40LG; the disease is COVID-19.